| |
|
|
|
Soleno Therapeutics Inc.  
|
|
2.03 0.08 (0.04%) |
05-22 16:00 |
|
Open: |
1.92 |
Pre close: |
1.95 |
Target:
|
2.51 
|
|
High: |
2.055 |
Low: |
1.92 |
Resistance:
|
2.15
2.51
|
|
Volume: |
82,818 |
Market Cap: |
65M |
Support:
|
1.96
1.85
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.99
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
2.01 |
Signal(12,26,9): |
-0.00  |
|
MA(100): |
1.87 |
Stochastic Oscillator |
%K(14,3):
|
57.09 |
|
MA(250): |
2.07 |
%D(3): |
52.28 |
|
Average Volume(K) |
3-Month: |
163642
|
52-Week |
High:
|
5.07 |
|
10-Days: |
9099 |
Low: |
1.11 |
|
RSI |
RSI(14):
|
51.41 |
Change(%): |
-3.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-74.3 |
Shares Out. (M) |
31.78 |
|
EPS Est. Current Year |
-1.350 |
Return on Assets (ttm) |
-46.0 |
Shares Float (M) |
30.75 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
48.70 |
|
Forward EPS |
-0.791 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.730 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.74 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
